<?xml version='1.0' encoding='utf-8'?>
<document id="23255551"><sentence text="Identification of multiple binding sites for substrate transport in bovine organic anion transporting polypeptide 1a2." /><sentence text="Organic anion transporting polypeptides (OATP) have been extensively recognized as key determinants of absorption, distribution, metabolism, and excretion of various drugs because of their broad substrate specificity, wide tissue distribution, and the involvement of drug-drug interaction" /><sentence text=" As the first cloned human OATP, OATP1A2 has been found to transport a wide spectrum of endogenous and exogenous compounds" /><sentence text=" Bovine Oapt1a2 shared high homology with the human transporter and is considered as its functional ortholog" /><sentence text=" In the present study, we expressed bovine Oatp1a2 in human embryonic kidney 293 cells and found that, unlike human OATP1A2, the transport of estrone-3-sulfate (E-3-S) exhibited biphasic saturation kinetics"><entity charOffset="142-159" id="DDI-PubMed.23255551.s5.e0" text="estrone-3-sulfate" /></sentence><sentence text=" The K(m) values are 0" /><sentence text="25 ± 0" /><sentence text="08 and 46" /><sentence text="6 ± 18" /><sentence text="5 µM, and V(max) values were 24" /><sentence text="5 ±4" /><sentence text="4 and 375 ± 142 pmol/mg protein/min for high- and low-affinity sites, respectively, suggesting the presence of multiple binding sites" /><sentence text=" Further study on other Oatp1a2 substrates showed that the high affinity component for E-3-S is responsible for the interaction with taurocholate, bromsulphthalein, and rifampicin and is sensitive to proton concentration change, whereas the low affinity binding site is only involved in the binding of the antitumor drug methotrexate and had no response to change of pH"><entity charOffset="133-145" id="DDI-PubMed.23255551.s13.e0" text="taurocholate" /><entity charOffset="147-163" id="DDI-PubMed.23255551.s13.e1" text="bromsulphthalein" /><entity charOffset="169-179" id="DDI-PubMed.23255551.s13.e2" text="rifampicin" /><entity charOffset="321-333" id="DDI-PubMed.23255551.s13.e3" text="methotrexate" /><pair ddi="false" e1="DDI-PubMed.23255551.s13.e0" e2="DDI-PubMed.23255551.s13.e0" /><pair ddi="false" e1="DDI-PubMed.23255551.s13.e0" e2="DDI-PubMed.23255551.s13.e1" /><pair ddi="false" e1="DDI-PubMed.23255551.s13.e0" e2="DDI-PubMed.23255551.s13.e2" /><pair ddi="false" e1="DDI-PubMed.23255551.s13.e0" e2="DDI-PubMed.23255551.s13.e3" /><pair ddi="false" e1="DDI-PubMed.23255551.s13.e1" e2="DDI-PubMed.23255551.s13.e1" /><pair ddi="false" e1="DDI-PubMed.23255551.s13.e1" e2="DDI-PubMed.23255551.s13.e2" /><pair ddi="false" e1="DDI-PubMed.23255551.s13.e1" e2="DDI-PubMed.23255551.s13.e3" /><pair ddi="false" e1="DDI-PubMed.23255551.s13.e2" e2="DDI-PubMed.23255551.s13.e2" /><pair ddi="false" e1="DDI-PubMed.23255551.s13.e2" e2="DDI-PubMed.23255551.s13.e3" /></sentence><sentence text="" /></document>